Crofelemer is a botanical anti-diarrheal agent and anthraquinone derivative specifically indicated for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.… Read more
Crofelemer is a botanical anti-diarrheal agent and anthraquinone derivative specifically indicated for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. By stabilizing intestinal epithelial tight junctions, this drug effectively reduces fluid secretion and inflammation without impacting gut motility. This category offers essential analytical tools for the pharmaceutical industry, including Crofelemer reference standards, process-related impurities, potential degradants, metabolites, and stable isotope-labelled compounds. These high-quality reference materials are critical for researchers and laboratories conducting impurity profiling, method development, and validation to ensure the efficacy, safety, and regulatory compliance of Crofelemer formulations. Utilizing these precisely characterized compounds supports robust quality control protocols throughout the drug development lifecycle and manufacturing process.